Rennova Health Stock Price, News & Analysis
Company Description
Rennova Health (OTC Link: RNVA) is a publicly traded diagnostics & research company in the Healthcare sector. The company has a market capitalization of $4.3M.
This page provides a comprehensive overview of RNVA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Rennova Health (RNVA) stock last traded at $0.0000. At a market capitalization of $4.3M, RNVA is classified as a micro-cap stock with approximately 43.1B shares outstanding.
Latest News
Rennova Health has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all RNVA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Rennova Health (RNVA) currently stands at 3 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Rennova Health (RNVA) currently stands at 1000.0 days, up 99899% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
RNVA Company Profile & Sector Positioning
Rennova Health (RNVA) operates in the Diagnostics & Research industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RNVA often look at related companies in the same sector, including Imd Companies (ICBU), Hypha Labs (FUNI), Leveljump Health (JMPHF), Interpace Biosciences Inc (IDXG), and Stagezero Life (SZLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RNVA's relative position within its industry.